BIDU-SW
09888
BOSS ZHIPIN-W
02076
NTES-S
09999
4
BABA-W
09988
5
TENCENT
00700
(FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | -62.78%-375.95M | 102.84%4.19M | -358.83%-230.96M | -341.45%-147.52M | -45.73%89.23M | -71.60%61.1M | -18.44%164.43M | 543.04%215.1M | 172.15%201.62M | 5.81%33.45M |
Profit adjustment | ||||||||||
Investment loss (gain) | -184.12%-7.31M | 18.40%-3.06M | 26.17%-2.57M | -164.94%-3.75M | -134.72%-3.48M | -132.67%-1.42M | 119.10%10.03M | -49.73%4.34M | -1,800.47%-52.53M | 770.98%8.63M |
Impairment and provisions: | -3.72%87.41M | -106.80%-1.03M | 3,981.42%90.78M | 815.81%15.13M | -87.27%2.22M | -155.71%-2.11M | 63.68%17.47M | 323.97%3.79M | 76.62%10.68M | -34.92%895.03K |
-Other impairments and provisions | -153.42%-2.26M | -107.80%-1.03M | 235.28%4.23M | 1,289.72%13.19M | -22.88%1.26M | 191.87%949.05K | 223.66%1.64M | -63.67%325.16K | -132.64%-1.32M | -34.92%895.03K |
Revaluation surplus: | -70.91%-67.83K | -1,466.67%-67.83K | -293.95%-39.69K | -152.83%-4.33K | -40.89%20.46K | -76.94%8.2K | -77.72%34.62K | -73.63%35.54K | 2,833.88%155.34K | 442.16%134.78K |
Asset sale loss (gain): | -168.83%-2.67M | 60.10%-395.91K | -43.62%-992.22K | ---992.22K | -17.68%-690.86K | ---- | -101.15%-587.08K | 99.54%-42.07K | 35,116.47%51.23M | ---9.17M |
-Loss (gain) on sale of property, machinery and equipment | -168.83%-2.67M | 60.10%-395.91K | -43.62%-992.22K | ---992.22K | -17.68%-690.86K | ---- | -101.15%-587.08K | 99.54%-42.07K | 35,116.47%51.23M | ---9.17M |
Depreciation and amortization: | 67.21%331.82M | 66.31%157.01M | 47.41%198.44M | 35.59%94.41M | -7.23%134.62M | -11.72%69.63M | -8.11%145.11M | 12.10%78.87M | 21.71%157.91M | 2.14%70.36M |
-Amortization of intangible assets | -0.83%4.28M | -0.97%2.14M | -0.40%4.31M | -0.46%2.16M | 0.98%4.33M | 1.03%2.17M | -45.03%4.29M | -44.49%2.14M | 27.06%7.8M | -9.29%3.86M |
-Other depreciation and amortization | 134.66%5.75M | 131.00%2.72M | 44.73%2.45M | 60.12%1.18M | -50.76%1.69M | -71.86%735.37K | 384.28%3.44M | 984.45%2.61M | 69.15%709.39K | -94.55%240.99K |
Financial expense | 52.22%155.34M | 75.26%80.12M | 25.06%102.05M | 14.12%45.72M | 18.08%81.6M | 13.48%40.06M | -40.73%69.11M | -22.64%35.3M | 6.76%116.59M | 1.86%45.63M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | -791.89%-373.05M | -2,345.72%-46.73M | 145.23%53.92M | -93.31%2.08M | -89.64%-119.22M | 189.38%31.12M | -218.53%-62.87M | 48.74%-34.82M | -270.47%-19.74M | -587.03%-67.93M |
Accounts receivable (increase)decrease | 106.51%20.56M | 80.08%-11.05M | 38.51%-315.75M | 87.81%-55.5M | -249.00%-513.51M | -171.91%-455.26M | -256.69%-147.14M | -237.76%-167.43M | 158.63%93.91M | -46.53%-49.57M |
Accounts payable increase (decrease) | -195.18%-360.1M | -332.88%-158.2M | 65.37%378.35M | -76.51%67.93M | 130.35%228.78M | 163.48%289.25M | -540.49%-753.87M | -577.65%-455.63M | -145.02%-117.7M | 0.90%95.39M |
Special items of business | 188.01%10.77M | -98.55%58.85K | -64.97%3.74M | 85.00%4.06M | -47.62%10.67M | 926.09%2.19M | 147.49%20.37M | 260.90%213.86K | -6,408.55%-42.91M | 33.34%-132.91K |
Adjustment items of business operations | -291.79%-524.02M | 18.78%20.79M | 372.06%273.22M | -45.93%17.5M | 82.01%-100.43M | 110.10%32.37M | -226.27%-558.27M | -350.72%-320.48M | 3.05%442.12M | -35.59%127.82M |
Net cash from operations | -285.31%-513.25M | -3.31%20.85M | 408.57%276.96M | -37.62%21.56M | 83.31%-89.76M | 110.79%34.56M | -234.74%-537.9M | -350.81%-320.26M | -6.81%399.22M | -35.59%127.69M |
Cash flow from investment activities | ||||||||||
Dividend received - investment | -35.71%10.02M | -48.76%5.02M | 123.14%15.59M | 375.04%9.8M | 1,958.24%6.98M | 791.27%2.06M | -58.78%339.37K | --231.43K | --823.22K | ---- |
Sale of fixed assets | --2.42M | --3.81M | ---- | ---- | 70,383.34%1.39M | ---- | -99.99%1.98K | -99.99%1.98K | 85,076.42%22.15M | --13.91M |
Purchase of fixed assets | 48.23%-487.32M | 43.39%-229.56M | -72.62%-941.3M | -113.74%-405.54M | -456.99%-545.3M | -430.60%-189.73M | 54.25%-97.9M | -34.44%-35.76M | -29.55%-213.99M | 55.22%-26.6M |
Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | 21.50%226.34M | --90.53M | 5,714.03%186.28M | ---- |
Recovery of cash from investments | 445.80%366.95K | ---- | -99.94%67.23K | -99.27%67.23K | 67.91%109.23M | -64.76%9.19M | -7.01%65.05M | 999.99%26.07M | 54,348.66%69.95M | --2.37M |
Cash on investment | ---- | ---- | 99.93%-67.23K | 99.93%-67.23K | -28,967.56%-100.07M | -53,358.12%-100.03M | 27.82%-344.26K | ---187.13K | 89.45%-476.93K | ---- |
Other items in the investment business | ---182.67K | ---182.67K | ---- | ---- | 333.96%19.36M | 91.17%5.05M | -39.25%4.46M | 453.56%2.64M | 478.12%7.34M | -51.39%477.12K |
Net cash from investment operations | 48.72%-474.69M | 44.18%-220.92M | -82.08%-925.71M | -44.71%-395.74M | -356.84%-508.4M | -427.37%-273.47M | 174.60%197.94M | 948.79%83.53M | 142.84%72.09M | 83.15%-9.84M |
Net cash before financing | -52.28%-987.94M | 46.53%-200.07M | -8.46%-648.75M | -56.62%-374.18M | -75.95%-598.16M | -0.92%-238.9M | -172.13%-339.95M | -300.88%-236.73M | 81.19%471.3M | -15.72%117.85M |
Cash flow from financing activities | ||||||||||
New borrowing | 25.79%3.83B | 2.45%1.74B | 34.20%3.04B | 17.53%1.69B | 37.69%2.27B | 59.16%1.44B | -18.50%1.65B | 7.41%905.5M | 95.54%2.02B | 170.63%843M |
Refund | -85.51%-3.17B | -9.13%-1.32B | -27.63%-1.71B | -39.28%-1.21B | -26.30%-1.34B | -50.92%-865.32M | 39.98%-1.06B | -4.56%-573.37M | -44.88%-1.77B | 4.47%-548.35M |
Dividends paid - financing | -34.26%-151.85M | -35.68%-71.82M | -43.85%-113.1M | -65.48%-52.93M | -41.40%-78.62M | -50.91%-31.99M | 26.13%-55.6M | 53.26%-21.2M | 22.24%-75.28M | -0.92%-45.35M |
Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.28B | --1.05M |
Other items of the financing business | -210.83%-97.99M | -719.54%-77.34M | 87.67%-31.53M | 96.30%-9.44M | -47.43%-255.73M | -40.76%-255.27M | 89.72%-173.46M | 14.29%-181.35M | -3,097.67%-1.69B | -308.48%-211.57M |
Net cash from financing operations | -65.59%409.67M | -36.47%270.77M | 100.09%1.19B | 47.66%426.2M | 66.09%594.99M | 122.74%288.64M | 260.93%358.25M | 234.19%129.58M | 1.31%-222.6M | 118.83%38.78M |
Effect of rate | 115.86%6.06K | -80.06%694.68 | -98.89%2.81K | -96.59%3.48K | 647.22%252.13K | 611.85%102.1K | 99.75%-46.07K | 98.59%-19.95K | -8,883.98%-18.59M | -1,958,246.36%-1.42M |
Net Cash | -206.73%-578.27M | 35.90%70.69M | 17,230.23%541.8M | 4.59%52.02M | -117.29%-3.16M | 146.42%49.74M | -92.64%18.29M | -168.41%-107.14M | 619.72%248.7M | 336.92%156.62M |
Begining period cash | 132.52%950.63M | 132.52%950.63M | -0.71%408.83M | -0.71%408.83M | 4.64%411.74M | 4.64%411.74M | 140.84%393.5M | 140.84%393.5M | 27.03%163.39M | 27.03%163.39M |
Cash at the end | -60.83%372.37M | 121.62%1.02B | 132.52%950.63M | -0.16%460.86M | -0.71%408.83M | 61.20%461.58M | 4.64%411.74M | -10.13%286.33M | 140.84%393.5M | 409.66%318.59M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
Auditor | Daxin Certified Public Accountants (Special General Partnership) | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | Lixin Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.